|

USD/CAD Price Analysis: Hits highest since Feb 2016, focus on weekly close

  • USD/CAD rose to four-year highs during the overnight trade. 
  • A weekly close above 1.3793 is needed to invalidate a lower highs setup. 

USD/CAD is currently trading at 1.3930, having hit a high of 1.3961 during the overnight trade. That was the highest level in over four years. 

The daily MACD histogram, an indicator used to identify trend changes and trend strength, is currently reporting the strongest bullish bias since May 2016. To put it another way, bullish sentiment looks to have reached extremes and a pullback could be in the offing. 

The pair may fall back to the psychological support at 1.29. Acceptance under that level would expose horizontal support at 1.3796. 

The case for a pullback would weaken if the spot rises above the overnight high of 1.3961. That would shift the focus to 1.40. 

Focus on the weekly close

A major bullish breakout on the weekly chart would be confirmed if the spot closes Friday above 1.3793 - a bearish lower high created in April 2017. 

The 14-week relative strength index is reporting overbought conditions with an above-70 print. The indicator, however, would gain credence if and when signs of seller exhaustion emerge on the price chart. 

Weekly chart

Trend: Bullish

Technical levels

USD/CAD

Overview
Today last price1.3934
Today Daily Change0.0011
Today Daily Change %0.08
Today daily open1.3923
 
Trends
Daily SMA201.3411
Daily SMA501.3255
Daily SMA1001.3219
Daily SMA2001.3217
 
Levels
Previous Daily High1.3961
Previous Daily Low1.3708
Previous Weekly High1.344
Previous Weekly Low1.3315
Previous Monthly High1.3465
Previous Monthly Low1.3202
Daily Fibonacci 38.2%1.3864
Daily Fibonacci 61.8%1.3805
Daily Pivot Point S11.3767
Daily Pivot Point S21.361
Daily Pivot Point S31.3513
Daily Pivot Point R11.4021
Daily Pivot Point R21.4118
Daily Pivot Point R31.4274

 

Author

Omkar Godbole

Omkar Godbole

FXStreet Contributor

Omkar Godbole, editor and analyst, joined FXStreet after four years as a research analyst at several Indian brokerage companies.

More from Omkar Godbole
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.